Shanmuga Hospital Ltd
₹ 45.2
-1.67%
24 Oct
- close price
About
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital situated in Salem, Tamil Nadu.[1]
Key Points
- Market Cap ₹ 61.6 Cr.
- Current Price ₹ 45.2
- High / Low ₹ 54.0 / 31.0
- Stock P/E 14.6
- Book Value ₹ 29.2
- Dividend Yield 0.00 %
- ROCE 17.2 %
- ROE 14.8 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 27.4 days to 67.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 38.94 | 37.11 | 40.63 | 45.41 | |
| 29.90 | 29.82 | 32.03 | 37.16 | |
| Operating Profit | 9.04 | 7.29 | 8.60 | 8.25 |
| OPM % | 23.22% | 19.64% | 21.17% | 18.17% |
| 0.09 | 0.15 | 0.34 | 0.23 | |
| Interest | 0.03 | 0.28 | 0.61 | 0.63 |
| Depreciation | 0.13 | 0.58 | 1.30 | 2.16 |
| Profit before tax | 8.97 | 6.58 | 7.03 | 5.69 |
| Tax % | 24.97% | 27.66% | 25.18% | 26.01% |
| 6.72 | 4.76 | 5.25 | 4.21 | |
| EPS in Rs | 840.00 | 595.00 | 5.36 | 3.09 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 5% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -14% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 27% |
| Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.08 | 0.08 | 9.80 | 13.61 |
| Reserves | 6.98 | 11.74 | 7.34 | 26.09 |
| -0.00 | 7.65 | 9.02 | 7.61 | |
| 3.59 | 3.58 | 7.76 | 5.47 | |
| Total Liabilities | 10.65 | 23.05 | 33.92 | 52.78 |
| 2.28 | 9.97 | 15.85 | 22.43 | |
| CWIP | -0.00 | -0.00 | 4.34 | -0.00 |
| Investments | -0.00 | 0.02 | 0.02 | 0.03 |
| 8.37 | 13.06 | 13.71 | 30.32 | |
| Total Assets | 10.65 | 23.05 | 33.92 | 52.78 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 1.92 | 2.95 | 9.58 | -12.64 | |
| -1.67 | -8.31 | -11.59 | -4.48 | |
| -0.03 | 7.37 | 0.90 | 16.39 | |
| Net Cash Flow | 0.21 | 2.00 | -1.12 | -0.73 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 44.15 | 57.64 | 62.53 | 63.98 |
| Inventory Days | 19.06 | 36.41 | ||
| Days Payable | 17.99 | 34.33 | ||
| Cash Conversion Cycle | 45.22 | 59.71 | 62.53 | 63.98 |
| Working Capital Days | 33.93 | 27.05 | -12.85 | 67.92 |
| ROCE % | 51.72% | 33.53% | 17.20% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Oct - Reg.74(5) certificate for 01.07.2025–30.09.2025 confirming no dematerialisation/rematerialisation requests received.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 Oct - Virtual analysts/investors meeting on 08-Oct-2025 with Arika Capital, Genuity Capital, BK Securities, Krishna Agencies, Family Office, HNIs.
-
Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To Healthcare
30 Sep - Certificate of Recognition at Times Healthcare Achievers – Tamil Nadu 2025 on 27 Sep 2025.
-
Closure Of Shanmuga Clinics
30 Sep - Shanmuga Clinic at Ayothiapattinam closed effective 30 Sep 2025; leased unit, minimal revenue impact.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
29 Sep - Investor meet on 08.10.2025 at 01:00 PM (IST)
Business Profile[1]
Shanmuga Hospital Limited is a leading multispecialty hospital in Salem, Tamil Nadu, with 151 beds, NABH/NABL accreditation, and strong oncology & surgical capabilities.